• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳酸脱氢酶(LDH)和中性粒细胞与淋巴细胞比值(NLR)作为炎症标志物,是老年患者新冠病毒疾病(COVID-19)并发呼吸衰竭的独立危险因素。

LDH and NLR, as inflammatory markers, the independent risk factors for COVID-19 complicated with respiratory failure in elderly patients.

作者信息

Wang Shan, Liu Jia, Hu Song, Mao Yongjun

机构信息

Shan Wang, Department of Geriatric Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.

Jia Liu, Department of Geriatric Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China.

出版信息

Pak J Med Sci. 2024 Oct;40(9):2112-2117. doi: 10.12669/pjms.40.9.8728.

DOI:10.12669/pjms.40.9.8728
PMID:39416623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11476168/
Abstract

OBJECTIVE

Lactate dehydrogenase (LDH) is an enzyme that is responsible for the production of lactic acid, which is a necessary byproduct when the body does not have enough oxygen. LDH levels in the blood can be used as a marker to predict mortality in patients with ARDS, severe COVID-19, and cancer. To analyze the clinical characteristics of COVID-19 in the elderly and the correlation between LDH and respiratory failure in COVID-19 patients, to improve the identification and management of this type of pneumonia by clinicians.

METHODS

This was a single-center retrospective study. We performed routine laboratory tests in 105 COVID-19 patients admitted to the affiliated hospital of Qingdao University (Qingdao, China) from October 1, 2022 to February 1, 2023. The diagnosis of respiratory failure was established based on the results of blood gas analysis upon admission.

RESULTS

The median age was 79 years. Among all univariable parameters, LDH, neutrophil to lymphocyte ratio (NLR) and Prothrombin Time (PT) were significantly independent risk factors of RF in elderly COVID-19 patients. LDH (AUC=0.829) also had a maximum specificity (96.5%), with the cutoff value of 280.5.

CONCLUSION

The levels of LDH, NLR, and PT may serve as potential indicators for elderly COVID-19 patients combined with respiratory failure. LDH, NLR and PT assays can be beneficial for patients who need closer respiratory monitoring and more aggressive supportive care to prevent a negative prognosis.

摘要

目的

乳酸脱氢酶(LDH)是一种负责产生乳酸的酶,乳酸是身体缺氧时产生的一种必要副产品。血液中的LDH水平可用作预测急性呼吸窘迫综合征(ARDS)、重症新型冠状病毒肺炎(COVID-19)和癌症患者死亡率的标志物。分析老年COVID-19患者的临床特征以及COVID-19患者中LDH与呼吸衰竭之间的相关性,以提高临床医生对这类肺炎的识别和管理能力。

方法

这是一项单中心回顾性研究。我们对2022年10月1日至2023年2月1日期间入住青岛大学附属医院(中国青岛)的105例COVID-19患者进行了常规实验室检查。根据入院时血气分析结果确定呼吸衰竭的诊断。

结果

中位年龄为79岁。在所有单变量参数中,LDH、中性粒细胞与淋巴细胞比值(NLR)和凝血酶原时间(PT)是老年COVID-19患者呼吸衰竭的显著独立危险因素。LDH(曲线下面积[AUC]=0.829)也具有最高的特异性(96.5%),截断值为280.5。

结论

LDH、NLR和PT水平可能作为老年COVID-19合并呼吸衰竭患者的潜在指标。LDH、NLR和PT检测可能有助于需要更密切呼吸监测和更积极支持治疗以防止不良预后的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ca/11476168/c6414e63030d/PJMS-40-2112-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ca/11476168/c6414e63030d/PJMS-40-2112-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ca/11476168/c6414e63030d/PJMS-40-2112-g001.jpg

相似文献

1
LDH and NLR, as inflammatory markers, the independent risk factors for COVID-19 complicated with respiratory failure in elderly patients.乳酸脱氢酶(LDH)和中性粒细胞与淋巴细胞比值(NLR)作为炎症标志物,是老年患者新冠病毒疾病(COVID-19)并发呼吸衰竭的独立危险因素。
Pak J Med Sci. 2024 Oct;40(9):2112-2117. doi: 10.12669/pjms.40.9.8728.
2
Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.乳酸脱氢酶和 C 反应蛋白可预测 COVID-19 患者的呼吸衰竭。
Clin Chim Acta. 2020 Oct;509:135-138. doi: 10.1016/j.cca.2020.06.012. Epub 2020 Jun 9.
3
[Biochemical analysis between common type and critical type of COVID-19 and clinical value of neutrophil/lymphocyte ratio].新型冠状病毒肺炎普通型与重型的生化分析及中性粒细胞/淋巴细胞比值的临床价值
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Jul 30;40(7):965-971. doi: 10.12122/j.issn.1673-4254.2020.07.08.
4
Prognostic value of neutrophil-to-lymphocyte ratio, lactate dehydrogenase, D-dimer, and computed tomography score in patients with coronavirus disease 2019.中性粒细胞与淋巴细胞比值、乳酸脱氢酶、D-二聚体和计算机断层扫描评分对新型冠状病毒肺炎患者的预后价值。
Aging (Albany NY). 2021 Sep 8;13(17):20896-20905. doi: 10.18632/aging.203501.
5
[Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].[老年重症新型冠状病毒肺炎患者继发噬血细胞性淋巴组织细胞增生症的临床特征及危险因素:一项多中心回顾性队列研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Aug;35(8):793-799. doi: 10.3760/cma.j.cn121430-20230510-00158.
6
Lactate dehydrogenase/albumin ratio as a prognostic factor in severe acute respiratory distress syndrome cases associated with COVID-19.乳酸脱氢酶/白蛋白比值作为 COVID-19 相关严重急性呼吸窘迫综合征患者的预后因素。
Medicine (Baltimore). 2022 Sep 23;101(38):e30759. doi: 10.1097/MD.0000000000030759.
7
Prognostic value of neutrophile-to-lymphocyte ratio (NLR) and lactate dehydrogenase (LDH) levels for geriatric patients with COVID-19.中性粒细胞与淋巴细胞比值(NLR)和乳酸脱氢酶(LDH)水平对 COVID-19 老年患者的预后价值。
BMC Geriatr. 2022 Apr 25;22(1):362. doi: 10.1186/s12877-022-03059-7.
8
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.2019冠状病毒病患者临床特征对重症疾病的预测作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.
9
Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.中性粒细胞与淋巴细胞比值和其他炎症标志物可预测住院 COVID-19 患者的不良结局。
Egypt J Immunol. 2022 Apr;29(2):57-67.
10
The neutrophil-to-lymphocyte ratio and lactate dehydrogenase combined in predicting liver metastasis and prognosis of colorectal cancer.中性粒细胞与淋巴细胞比值和乳酸脱氢酶联合用于预测结直肠癌肝转移及预后。
Front Med (Lausanne). 2023 Jun 23;10:1205897. doi: 10.3389/fmed.2023.1205897. eCollection 2023.

引用本文的文献

1
LASSO Logistic Regression for Predicting Postoperative Severe Pain After Hepatic Hemangioma Ablation.用于预测肝血管瘤消融术后严重疼痛的套索逻辑回归分析
J Pain Res. 2025 Apr 9;18:1909-1921. doi: 10.2147/JPR.S510668. eCollection 2025.
2
Role of Artificial Intelligence in Identifying Vital Biomarkers with Greater Precision in Emergency Departments During Emerging Pandemics.人工智能在新发大流行期间急诊科更精准识别关键生物标志物中的作用
Int J Mol Sci. 2025 Jan 16;26(2):722. doi: 10.3390/ijms26020722.
3
Pulmonary embolism in children with mycoplasma pneumonia: can it be predicted?

本文引用的文献

1
The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients.炎症性疾病中的乳酸和乳酸脱氢酶,以及 COVID-19 患者的主要危险因素。
Inflammation. 2022 Dec;45(6):2091-2123. doi: 10.1007/s10753-022-01680-7. Epub 2022 May 19.
2
Lymphopenia: A useful predictor of COVID-19 disease severity and mortality.淋巴细胞减少:COVID-19疾病严重程度和死亡率的有用预测指标。
Pak J Med Sci. 2021 Nov-Dec;37(7):1984-1988. doi: 10.12669/pjms.37.7.4085.
3
Proteomic and metabolomic investigation of serum lactate dehydrogenase elevation in COVID-19 patients.
支原体肺炎患儿的肺栓塞:能否预测?
Eur J Clin Microbiol Infect Dis. 2025 Feb;44(2):393-403. doi: 10.1007/s10096-024-05014-3. Epub 2024 Dec 17.
COVID-19 患者血清乳酸脱氢酶升高的蛋白质组学和代谢组学研究。
Proteomics. 2021 Aug;21(15):e2100002. doi: 10.1002/pmic.202100002. Epub 2021 May 28.
4
Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis.入院时中性粒细胞与淋巴细胞比值预测 COVID-19 患者严重程度和死亡率的荟萃分析。
Am J Emerg Med. 2021 Apr;42:60-69. doi: 10.1016/j.ajem.2021.01.006. Epub 2021 Jan 9.
5
Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19).中性粒细胞与淋巴细胞比值和 C 反应蛋白水平对 2019 冠状病毒病(COVID-19)的应用价值。
Scand J Clin Lab Invest. 2020 Nov;80(7):536-540. doi: 10.1080/00365513.2020.1803587. Epub 2020 Aug 17.
6
Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study.乳酸脱氢酶,重症新型冠状病毒肺炎患者的独立危险因素:一项回顾性观察研究
Aging (Albany NY). 2020 Jun 24;12(12):11245-11258. doi: 10.18632/aging.103372.
7
Epidemiology of CoViD-19 Pandemic: Recovery and mortality ratio around the globe.2019冠状病毒病大流行的流行病学:全球范围内的康复率和死亡率
Pak J Med Sci. 2020 May;36(COVID19-S4):S79-S84. doi: 10.12669/pjms.36.COVID19-S4.2660.
8
COVID-19 and the elderly: insights into pathogenesis and clinical decision-making.COVID-19 与老年人:发病机制和临床决策的新视角。
Aging Clin Exp Res. 2020 Aug;32(8):1599-1608. doi: 10.1007/s40520-020-01631-y. Epub 2020 Jun 16.
9
Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.乳酸脱氢酶和 C 反应蛋白可预测 COVID-19 患者的呼吸衰竭。
Clin Chim Acta. 2020 Oct;509:135-138. doi: 10.1016/j.cca.2020.06.012. Epub 2020 Jun 9.
10
COVID-19: progression of disease and intravascular coagulation - present status and future perspectives.COVID-19:疾病进展与血管内凝血——现状与未来展望。
Clin Chem Lab Med. 2020 Jun 25;58(7):1029-1036. doi: 10.1515/cclm-2020-0502.